We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cell Line Engineering Makes Well-characterized Antibody More Accessible

News   Aug 01, 2018 | Original story sourced from the US National Institute of Standards and Technology

 
New Cell Lines Produce an Antibody Key for Biologic Drug Production

HeLa cancer cells appear green wherever mouse monoclonal antibodies (mAb) have bound to tubulin, a structural protein important in cell division. Binding to tubulin and preventing cell growth is one way that mAb drugs could kill tumors -- the type of research that may benefit from the use of NIST's monoclonal antibody reference material, NISTmAb. Credit: ©EnCor Biotechnology Inc.

 
 
 

RELATED ARTICLES

Vitamin D Metabolites Influence T Cell Priming

News

Fresh insights on the effect of vitamin D on the immune system add to the greater picture of how vitamin D might influence susceptibility to inflammatory diseases.

READ MORE

CRISPR Treats Lethal Lung Disease Before Birth in Animal Model

News

Using CRISPR gene editing, a team from Children's Hospital of Philadelphia (CHOP) and Penn Medicine have thwarted a lethal lung disease in an animal model in which a harmful mutation causes death within hours after birth.

READ MORE

Guarding Against Cancer

News

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE